Kovack Advisors, Inc. Amgen Inc Transaction History

Kovack Advisors, Inc.

$887 Million
Q2 2024

A detailed history of Kovack Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 2,154 shares of AMGN stock, worth $680,664. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,154

Previous 3,694 41.69%

Holding current value

$680,664

Previous $1.05 Million 35.9%

% of portfolio

0.08%

Previous 0.13%

38 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $404,635 - $491,737	-1,540 Reduced 41.69%	2,154 $673,000
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $191,166 - $230,762	711 Added 23.84%	3,694 $1.05 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $36,053 - $40,672	141 Added 4.96%	2,983 $859,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $36,514 - $45,333	-167 Reduced 5.55%	2,842 $763,000
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $200,985 - $237,661	-938 Reduced 23.76%	3,009 $668,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $110,185 - $134,297	488 Added 14.11%	3,947 $954,000
Q4 2022 Feb 22, 2023	SELL	$229.03 - $291.01 $60,463 - $76,826	-264 Reduced 7.09%	3,459 $908,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $248,252 - $279,983	-1,106 Reduced 22.9%	3,723 $839,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $211,330 - $235,173	916 Added 23.41%	4,829 $1.18 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $280,884 - $310,732	1,281 Added 48.67%	3,913 $946,000
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $22,473 - $25,718	-113 Reduced 4.12%	2,632 $592,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $3,184 - $3,730	-15 Reduced 0.54%	2,745 $584,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $3,503 - $3,887	-15 Reduced 0.54%	2,760 $673,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $17,752 - $20,688	80 Added 2.97%	2,775 $690,000
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $4,976 - $5,926	23 Added 0.86%	2,695 $620,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $34,493 - $38,359	147 Added 5.82%	2,672 $679,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $27,891 - $34,226	-141 Reduced 5.29%	2,525 $596,000
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $485,851 - $644,372	2,666 New	2,666 $541,000
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $665,073 - $854,848	-3,515 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $37,259 - $44,644	-214 Reduced 5.74%	3,515 $680,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $195,205 - $228,825	-1,171 Reduced 23.9%	3,729 $687,000
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $234,226 - $264,024	-1,295 Reduced 20.9%	4,900 $931,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $274,022 - $319,872	1,536 Added 32.97%	6,195 $1.21 Million
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $51,695 - $58,280	279 Added 6.37%	4,659 $966,000
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $294,572 - $330,868	-1,774 Reduced 28.83%	4,380 $808,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $23,381 - $27,324	-138 Reduced 2.19%	6,154 $1.05 Million
Q4 2017 May 15, 2018	SELL	$168.79 - $188.59 $46,079 - $51,485	-273 Reduced 4.16%	6,292 $1.09 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $2,363 - $2,640	14 Added 0.21%	6,565 $1.14 Million
Q3 2017 Aug 02, 2018	BUY	$167.29 - $191.0 $38,978 - $44,503	233 Added 3.69%	6,551 $1.22 Million
Q2 2017 Aug 30, 2018	BUY	N/A	1,985 Added 45.81%	6,318 $1.09 Million
Q1 2017 Sep 05, 2018	BUY	N/A	161 Added 3.86%	4,333 $711,000
Q4 2016 Sep 10, 2018	BUY	N/A	329 Added 8.56%	4,172 $610,000
Q3 2016 Sep 25, 2018	BUY	N/A	88 Added 2.34%	3,843 $641,000
Q2 2016 Oct 01, 2018	SELL	N/A	-2,309 Reduced 38.08%	3,755 $571,000
Q1 2016 Oct 12, 2018	BUY	N/A	2,227 Added 58.04%	6,064 $909,000
Q4 2015 Oct 18, 2018	BUY	N/A	111 Added 2.98%	3,837 $623,000
Q3 2015 Oct 29, 2018	BUY	N/A	1,843 Added 97.88%	3,726 $515,000
Q2 2015 Nov 06, 2018	BUY	N/A	1,883	1,883 $289,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Amgen Inc Transaction History